Wednesday, October 22, 2014 Last update: 12:33 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 9, 2014

Companies mentioned in this article: Horizon Pharma

DEERFIELD, IL -- (Marketwired) -- 04/25/14 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that its first quarter 2014 financial results will be released on Friday, May 9, 2014. Following the announcement, Horizon's management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company's financial and operating results and provide a general business update.

The live webcast and a replay may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 1-888-338-8373 (U.S.) or 973-872-3000 (international) to listen to the conference call. The conference ID number for the live call is 29164068. Telephone replay will be available approximately two hours after the call. To access the replay, please call 1-855-859-2056 (U.S.) or 404-537-3406 (international). The conference ID number for the replay is 29164068.

About Horizon Pharma
Horizon Pharma, Inc. is a commercial stage, specialty pharmaceutical company that markets DUEXIS®, VIMOVO® and RAYOS®/LODOTRA®, which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire or in-license additional innovative medicines where it can execute a targeted commercial approach among specific target physicians such as primary care physicians, orthopedic surgeons, and rheumatologists, while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit www.horizonpharma.com.


Contact:

Contacts:
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Email Contact